These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7888046)

  • 1. Donor-specific cytotoxicity induced by allogeneic intestinal epithelial cells in a sponge matrix model.
    Li XC; Zhong R; Zhu L; Grant D
    Transpl Int; 1995; 8(1):13-9. PubMed ID: 7888046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic lymphocyte proliferation stimulated by small intestine-derived epithelial cells.
    Li XC; Almawi W; Jevnikar A; Tucker J; Zhong R; Grant D
    Transplantation; 1995 Jul; 60(1):82-9. PubMed ID: 7624948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo mechanisms of alloreactivity. I. Frequency of donor-reactive cytotoxic T lymphocytes in sponge matrix allografts.
    Orosz CG; Zinn NE; Sirinek L; Ferguson RM
    Transplantation; 1986 Jan; 41(1):75-83. PubMed ID: 2934878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MHC class II presenting cells are necessary for the induction of intrathymic tolerance.
    Goss JA; Nakafusa Y; Flye MW
    Ann Surg; 1993 May; 217(5):492-9; discussion 499-501. PubMed ID: 8489312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide.
    Chowdhury NC; Saborio DV; Garrovillo M; Chandraker A; Magee CC; Waaga AM; Sayegh MH; Jin MX; Oluwole SF
    Transplantation; 1998 Oct; 66(8):1059-66. PubMed ID: 9808492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo mechanisms of alloreactivity. II. Allospecificity of cytotoxic T lymphocytes in sponge matrix allografts as determined by limiting dilution analysis.
    Orosz CG; Zinn NE; Sirinek LP; Ferguson RM
    Transplantation; 1986 Jan; 41(1):84-92. PubMed ID: 2934879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infiltrating CD45RC- T cells are associated with immunologic unresponsiveness induced by donor class I major histocompatibility complex antigens in rats.
    Yamaguchi Y; Miyanari N; Ichiguchi O; Akizuki E; Matsumura F; Matsuda T; Okabe K; Liang J; Ohshiro H; Mori K; Ogawa M
    Hepatology; 1998 Aug; 28(2):450-8. PubMed ID: 9696011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo mechanisms of alloreactivity. III. Development of donor-specific antibody in sponge matrix allografts.
    Sirinek LP; Zinn NE; Ferguson RM; Orosz CG
    Transplantation; 1986 Mar; 41(3):349-56. PubMed ID: 3952801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of in vivo and in vitro immune response to purified hepatocytes.
    Bumgardner GL; Matas AJ; Chen S; Cahill D; Cunningham TR; Payne WD; Bach FH; Ascher NL
    Transplantation; 1990 Feb; 49(2):429-36. PubMed ID: 1968299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of parathyroid graft rejection suggests alloantigen-specific production of nitric oxide by iNOS-positive intragraft macrophages.
    Matuschek A; Ulbrich M; Timm S; Schneider M; Thomas Germer C; Ulrichs K; Otto C
    Transpl Immunol; 2009 Sep; 21(4):183-91. PubMed ID: 19409993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver-derived dendritic cells induce donor-specific hyporesponsiveness: use of sponge implant as a cell transplant model.
    Chiang YJ; Lu L; Fung JJ; Qian S
    Cell Transplant; 2001; 10(3):343-50. PubMed ID: 11437079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of hepatic allograft rejection in the rat by mitomycin C-treated donor splenocytes: analysis of the immune status.
    Yamaguchi Y; Mori K; Bollinger RR
    J Clin Lab Immunol; 1990 Jun; 32(2):59-66. PubMed ID: 1967040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathymic injection of donor alloantigens induces specific tolerance to cardiac allografts.
    Goss JA; Nakafusa Y; Yu S; Flye MW
    Transplantation; 1993 Jul; 56(1):166-73. PubMed ID: 8333039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that pretransplant donor blood transfusion prevents rat renal allograft dysfunction but not the in situ cellular alloimmune or morphologic manifestations of rejection.
    Ruiz P; Coffman TM; Howell DN; Straznickas J; Scroggs MW; Baldwin WM; Klotman PE; Sanfilippo F
    Transplantation; 1988 Jan; 45(1):1-7. PubMed ID: 3276038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell subsets responding to purified hepatocytes and evidence of indirect recognition of hepatocyte major histocompatibility complex class I antigen. I. The role of L3T4+ T cells in the development of allospecific cytotoxicity in hepatocyte-sponge matrix allografts.
    Bumgardner GL; Chen S; Almond PS; Bach FH; Ascher NL; Matas AJ
    Transplantation; 1992 Apr; 53(4):857-62. PubMed ID: 1566351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that indefinite survival of small bowel allografts achieved by a brief course of cyclosporine or FK506 is not due to systemic hyporesponsiveness.
    Langrehr JM; Hoffman RA; Demetris AJ; Lee KK; Neuhaus P; Wren SM; Ildstad ST; Schraut WH
    Transplantation; 1992 Sep; 54(3):505-10. PubMed ID: 1384185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of donor-specific unresponsiveness to rat cardiac allografts by intrathymic injection of UV-B-irradiated donor spleen cells.
    Oluwole SF; Chowdhury NC; Fawwaz RA
    Transplantation; 1993 Jun; 55(6):1389-95. PubMed ID: 8516824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of donor-specific tolerance to cardiac but not skin or renal allografts by intrathymic injection of splenocyte alloantigen.
    Nakafusa Y; Goss JA; Mohanakumar T; Flye MW
    Transplantation; 1993 Apr; 55(4):877-82. PubMed ID: 8475563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of allochimeric proteins to mitigate graft-versus-host and host-versus-graft immune responses to rat small bowel allografts.
    Okamoto M; Stepkowski SM; Wang M; Kahan BD
    Transplantation; 2000 Oct; 70(7):1060-7. PubMed ID: 11045643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic suppression mediated by genetically modified hepatocytes expressing secreted allo-MHC class I molecules.
    Graeb C; Scherer MN; Knechtle SJ; Geissler EK
    Hum Immunol; 1998 Jul; 59(7):415-25. PubMed ID: 9684991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.